History
2022
Jan.
certified for ‘ISO27001 and ISO27799’ at the Same Time
Acquired the highest-grade genetic analysis certification in Korea for 6 years
Acquired College of American Pathologists(CAP) for second consecutive year
Participated in ‘Medlab Middle East 2022’, the world’s largest diagnostic and medical equipment exhibition
Feb.
Completed System for Award Management (SAM) and Federal Supply Schedule (FSS) of US Federal Procurement Service
Presentation of Liquid biopsy at the 29th Molecular & Precision Med Tri-conference
Mar. The first delivery of exports to the US federal government procurement market
2021
Mar. Liquid biopsy Clinical GMP approved by Ministry of Food and Drug Administration
Apr. EDGC executives and employees participate in “Love sharing, Blood Donation Campaign” to overcome COVID-19
May. Launch Liquid Biopsy ONCOCATCH™
Jul.
Selected as an excellent company in 2020’ IR confidence index among listed companies in Korea
Acquired Canada's "Natural Life Nutrition" Health Functional Food Company
Aug.
Healthcare platform joint development, MOU with E-Land
Opened EDGC Data integration center
Sept.
Signed the joint marketing agreement for liquid biopsy ‘ONCOCATCH™’ (Molecular Health)
Joint research on Genetic Data Combination and Precision Medicine (Ewha Womans University Medical Center)
Oct. Participated in the WellCare Research Project, building an artificial intelligence(AI) technology support platform
Nov. Participated in 2021 Int' BioPharm Exhibition
Dec.
Liquid biopsy, selected as a genome representative company in the government-led Big 3 Project
58th Trade Day, awarded 'Tower of $10 Million Export'
2020
Jan. Sign the joint research agreement on Liquid Biopsy(China Medical University, Fudan Univ. Cancer Center)
Feb Launch YouWho, exclusive DNA lineage test service in Korea
Mar.
Sign the research agreement of medical AI based on genomics (ChungAng University Hospital, CAU)
Sign the research agreement of 10,000 Genome Project(GN Major Clinic, Chunlab, B Link Healthcare)
May.
Sign partnership agreement with DxGen
Sign the co-development agreement of Bio-Cosmetics with CHARIS GEN
Merge EDGC Healthcare
Jun.
Selected as 2020 Small Giant Company of Korea by the Ministry of SMEs and Startups
Sign the co-development agreement of Lab-grown meat business with Noah Biotech
Jul. Selected as innovative growth company in Bio-Health, Big 3
2019
Feb.
Launch ACMG59 in the USA
Sign the agreement of medical marijuana R&D with SCG
Apr.
Sign the cooperation agreement of precision medicine based on genome with MizMedi Hospital
Sign the co-development agreement of oncolytic virus treatment based genome with ViroCure
May. Sign the co-development agreement of bio-cosmetics based on genes with LUI&LEI
Jun.
Launch Liquid Biopsy in ASCO
Awarded the Chairman of the Korea Federation of SMEs
Jul. Sign the agreement for cooperation between industry and educational organizations with Sookmyung Woman’s Univ.
Aug. Open the Wellness Center
Sept. Sign the cooperation agreement of precision medicine based on genome with GN Major Clinic
Nov.
Selected as the National MCI∙Dementia Project Organization by the Ministry of Health and Welfare
NICE® is selected as the Korean World-class Product Award 2019 by the Ministry of Trade, Industry and Energy
Dec. Certified for DTC Pilot Project by the Ministry of Health and Welfare
2018
Jan.
Register for a patent (Method of Detecting Chromosomal Abnormalities)
Register for a patent (Novel Method Capable of Differentiating Fetal Sex and Fetal Sex Chromosome Abnormality on Various Platforms)
Mar.
Sign the cooperation agreement between Company-IBK-University
Sign the cooperation agreement Human Project with Incheon National University
Apr. Launch MYGENPLAN®
Sign the sales contract for EyeGene® with AGBio Diagnostics and SCD Pharm
Awarded Best Technology Award of Incheon Scientific Technology Awards (Ph.D Sung-Hoon Lee)
Register for a patent (Method for Predicting Organ Transplant Rejection Using Next-Generation Sequencing)
May.
Selected as AI-Based Precision Medicine Solution Bureau organized by the Ministry of Science and ICT
Selected as Distributed Bio-Health Big-Data Organization organized by the Ministry of Trade, Industry and Energy
Jun. Listed on Korea Securities Dealer Automated Quotation (KOSDAQ)
Jul.
Sign the cooperation agreement of healthcare contents development with KoreaMedicare
Establish EDGC Asia in Hong Kong
Aug.
Receive CAP Certificate
Sign the co-development and sales agreement for NGS-based product (SolGent)
Sign the co-development agreement of personalized skin diagnosis and solution based on genes (DOHU, XINMAY SKIN)
Sign the cooperation agreement with Medical Center of the Executive Office of the President of the Republic of Tajikistan
Sep.
Undertake CNS Healthcare’s Stocks
Sign the contract for personalized language education business with EKYSS
Rank No.1 in Services/Manufacturing at Consumer Satisfaction Brand Awards
Sigh the cooperation agreement with Yancheng City, China
Oct.
Sign the research agreement for genetic approach for Agent Orange victims with VAVA
Sign the cooperation agreement for genetic information protection with EVERSPIN
Appointed new CEO Myung-Hee Lee to EDGC Healthcare
Nov. Sign the cooperation agreement for expansion of Total care service converged with genetic analysis (HealthMax, Mediage)
2017
Feb. Launch bebegene®
Mar. Sign the cooperation agreement in the life sciences with Ghent University
Apr. Establish EDGC, Inc. in the United States of America
May. Launch MyEyeGene®
Jul.
Sign the co-development agreement of precision diagnosis with Ewha Womans University Medical Center
Sign partnership agreement with GPBio
Sign partnership agreement with BRIA Lab
Sept.
Launch Wine Matching Service
Apply for a patent (Method and System for Providing Personalized Wine Information by Gene Based on Individual and Terminal Using Same)
Oct.
Participate in World Knowledge Forum – the session, titled ‘100 dollars genome’ as a moderator
Host the 2nd Personal Genome Revolution Seminar with Incheon National University
Launch gene2me® Plus
Nov. Announce to launch NIPT applying AI technology
Dec.
Begin to provide NICE® through Cordlife branches in the Philippines and Indonesia
Begin to provide NICE® through BRIA Lab in Thailand
Sign the agreement for cooperation between industry and educational organizations with Incheon National University
2016
Jan. Apply for a patent (Method of Detecting Chromosomal Abnormalities)
Mar. Apply for a patent (Method for Diagnosing Fetal Chromosomal Aneuploidy)
Apr. Sign the memorandum of understanding for early cancer diagnosis (CytoGen)
May. Sign the research contract for organ transplant patient monitoring (B Hospital)
Jun.
Selected as Global Screening Array (GSA) consortium’s partner
Sign the support agreement for human care contents development (Kyungpook National University)
Apply for a patent (Method for Determining the Presence or Absence of Aneuploidies and Copy Number Variations in a Sample by Using 2-Dimensional Distribution of Values)
Launch gene2me®
Aug.
Sign the contract for diagnostic product development and sale activation with Genoheal
Sign the agreement for human resource development customized for local industry with Incheon National University
Sign the agreement of solution development based on genes with Genodoctor
Co-develop the genetic testing for personalized oriental medicine treatment with Familiar Hospital
Signed the co-development agreement of personalized cosmetics based on genetic testing for skin type
with LUI & LEI and Genoheal
Sign the agreement for long term work experience with Incheon National University
Sept.
Introduce the matrix school system with Incheon National University
Register a patent (Biomarkers Indicative of Down Syndrome and Their Uses)
Nov. Sign the agreement for cooperation between industry and educational organizations with Incheon National University
Dec.
Acquire CE certificate for NICE® Check Control Kit/LOD Kit
Acquire CE and KFDA certificate for NICE® Check cfDNA Tube
2015
Mar. Sign the development agreement for bioinformatics based on cloud with Maverix (USA)
Apr. Apply for a patent (Method for Predicting Organ Transplant Rejection Using Next-Generation Sequencing)
Aug. Apply for a patent (Novel Method Capable of Differentiating Fetal Sex and Fetal Sex Chromosome Abnormality on Various Platforms)
Oct. Launch NICE® Check Control/LOD/cfDNA Tube at 2015 ASHG
Nov. Launch NICE®, CLIA-Certified Non-Invasive Prenatal Test (NIPT)
2014
Jan. Acquire Company Annex Research Institute Certificate (No. 2014110065)
May. Apply for a patent (Biomarkers Indicative of Down Syndrome and Their Uses)
Jul.
Launch Verifi®, Illumina’s Non-Invasive Prenatal Test (NIPT) domestically for the first time
Sign the joint research agreement on Hospital Acquired Infection (HAI) with Bioinnovation (Swiss)
Dec.
Organize Organ Transplant Rejection Monitoring Project with Pennsylvania University and Cornell University
Develop BRCARE®, female cancer prediction test
2013
May. Establish EDGC
Sept. Upload EDGC Annotator on Illumina’s BaseSpace